Get the Stockscreener App
46.70
6.11%
2.69
After Hours:
46.70
Veracyte Inc stock is traded at $46.70, with a volume of 1.23M.
It is up +6.11% in the last 24 hours and up +27.14% over the past month.
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder). In addition, its Percepta Nasal Swab test is being run in CLIA labs in support of clinical studies.
See More
Previous Close:
$44.01
Open:
$43.83
24h Volume:
1.23M
Relative Volume:
1.28
Market Cap:
$3.69B
Revenue:
$399.58M
Net Income/Loss:
$-54.04M
P/E Ratio:
-62.27
EPS:
-0.75
Net Cash Flow:
$40.13M
1W Performance:
+18.89%
1M Performance:
+27.14%
6M Performance:
+71.94%
1Y Performance:
+17.96%
1-Day Range:
$43.24
$46.93
1-Week Range:
$37.98
$46.93
52-Week Range:
$22.61
$47.32
Veracyte Inc Stock (VCYT) Company Profile
Name
Veracyte Inc
Sector
Industry
Phone
(650) 243-6300
Address
6000 SHORELINE COURT, SUITE 300, SOUTH SAN FRANCISCO, CA
Compare VCYT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VCYT
Veracyte Inc
|
46.70 | 3.48B | 399.58M | -54.04M | 40.13M | -0.75 |
|
TMO
Thermo Fisher Scientific Inc
|
586.07 | 220.72B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
226.98 | 160.62B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
752.14 | 57.96B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
153.60 | 42.88B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
228.18 | 38.30B | 15.90B | 1.28B | 2.21B | 7.2842 |
Veracyte Inc Stock (VCYT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-20-25 | Initiated | Canaccord Genuity | Hold |
| Mar-20-25 | Initiated | Craig Hallum | Buy |
| Dec-05-24 | Downgrade | Goldman | Buy → Neutral |
| Nov-15-24 | Initiated | Wolfe Research | Outperform |
| Oct-16-24 | Initiated | UBS | Buy |
| Oct-10-24 | Initiated | Guggenheim | Buy |
| Feb-23-24 | Reiterated | Needham | Buy |
| Jan-18-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jan-05-23 | Initiated | Scotiabank | Sector Outperform |
| Jan-07-22 | Initiated | Stephens | Overweight |
| Nov-18-21 | Resumed | Goldman | Buy |
| Jun-15-21 | Initiated | Raymond James | Outperform |
| Feb-18-21 | Resumed | Needham | Buy |
| Jan-28-21 | Initiated | Truist | Buy |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Sep-09-20 | Initiated | Morgan Stanley | Underweight |
| Jul-31-19 | Initiated | Lake Street | Buy |
| Jul-02-19 | Initiated | Needham | Buy |
| Nov-29-18 | Downgrade | Janney | Buy → Neutral |
| Oct-31-18 | Upgrade | Janney | Neutral → Buy |
| Nov-07-17 | Downgrade | Janney | Buy → Neutral |
| Nov-07-17 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Aug-31-17 | Resumed | BTIG Research | Buy |
| Nov-14-16 | Resumed | Leerink Partners | Outperform |
| Dec-18-15 | Initiated | Cantor Fitzgerald | Buy |
| Jun-11-15 | Reiterated | Leerink Partners | Outperform |
| Nov-26-13 | Initiated | William Blair | Outperform |
View All
Veracyte Inc Stock (VCYT) Latest News
Veracyte Stock Soars Amid Strong Earnings and New Price Targets - timothysykes.com
Veracyte Stock Surges Amid Investor Conferences and Robust Earnings - StocksToTrade
Is Veracyte Inc a good long term investmentMoving Average Crossovers & AI-Based Insights for Consistent Profits - earlytimes.in
Veracyte Stock Soars Amid Revenue and EPS Surprises - timothysykes.com
Veracyte, Inc. (NASDAQ:VCYT) Stock Catapults 27% Though Its Price And Business Still Lag The Industry - simplywall.st
Insider Sell: Jens Holstein Sells 10,000 Shares of Veracyte Inc (VCYT) - GuruFocus
Veracyte Director Jens Holstein Sells 10,000 Shares - TradingView
Dir Holstein Sells 10,000 ($423.6K) Of Veracyte Inc [VCYT] - TradingView
[Form 4] VERACYTE, INC. Insider Trading Activity - Stock Titan
Will Veracyte Inc. (12V) stock sustain bullish trend into 2025Earnings Overview Summary & Safe Entry Point Identification - newser.com
Can Veracyte Inc. (12V) stock surprise markets with earningsTrade Volume Summary & Fast Exit Strategy with Risk Control - newser.com
Veracyte at Stephens Conference: Strategic Growth and Expansion By Investing.com - Investing.com India
Veracyte at Stephens Conference: Strategic Growth and Expansion - Investing.com
Veracyte at Jefferies London: Strategic Expansion and Growth By Investing.com - Investing.com Nigeria
Veracyte at Jefferies London: Strategic Expansion and Growth - Investing.com
Will Veracyte Inc. stock gain from government policiesShort Setup & Weekly High Conviction Trade Ideas - newser.com
Will Veracyte Inc. (12V) stock profit from fiscal stimulus2025 Key Lessons & Capital Efficiency Focused Strategies - newser.com
Can Veracyte Inc. (12V) stock sustain breakout momentumRisk Management & Daily Entry Point Alerts - newser.com
How Veracyte Inc. stock performs in interest rate cyclesPortfolio Return Summary & Daily Profit Focused Screening - newser.com
How to read the order book for Veracyte Inc.July 2025 Catalysts & Risk Adjusted Buy/Sell Alerts - newser.com
Tools to assess Veracyte Inc.’s risk profileEarnings Beat & AI Enhanced Trading Alerts - newser.com
Is Veracyte Inc. (12V) stock cheap vs fundamentalsGap Down & Verified Momentum Stock Watchlist - newser.com
Heatmap analysis for Veracyte Inc. and competitorsMarket Trend Review & Step-by-Step Trade Execution Guides - newser.com
Veracyte Inc Stock (VCYT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.35%
1.41%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):